FERRACIN, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 9.824
AS - Asia 4.662
EU - Europa 2.617
SA - Sud America 693
AF - Africa 101
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.919
Nazione #
US - Stati Uniti d'America 9.632
SG - Singapore 1.855
CN - Cina 1.117
BR - Brasile 529
VN - Vietnam 513
DE - Germania 509
IT - Italia 403
UA - Ucraina 389
HK - Hong Kong 366
TR - Turchia 298
GB - Regno Unito 297
FI - Finlandia 238
PL - Polonia 153
FR - Francia 141
SE - Svezia 134
RU - Federazione Russa 106
JP - Giappone 101
CA - Canada 91
IN - India 86
MX - Messico 84
ID - Indonesia 71
AR - Argentina 67
BD - Bangladesh 58
NL - Olanda 56
ZA - Sudafrica 35
ES - Italia 33
IQ - Iraq 33
AT - Austria 29
BE - Belgio 28
RO - Romania 27
CO - Colombia 24
EC - Ecuador 20
LT - Lituania 20
PK - Pakistan 19
SA - Arabia Saudita 18
CL - Cile 17
UZ - Uzbekistan 17
AU - Australia 16
TN - Tunisia 16
PH - Filippine 15
CZ - Repubblica Ceca 14
VE - Venezuela 12
EG - Egitto 11
IR - Iran 11
MY - Malesia 11
KR - Corea 10
CH - Svizzera 8
DZ - Algeria 8
KE - Kenya 8
MA - Marocco 8
NP - Nepal 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
JO - Giordania 6
LB - Libano 6
OM - Oman 6
PY - Paraguay 6
JM - Giamaica 5
PE - Perù 5
TH - Thailandia 5
AZ - Azerbaigian 4
BO - Bolivia 4
ET - Etiopia 4
GR - Grecia 4
IE - Irlanda 4
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
LY - Libia 2
MU - Mauritius 2
PA - Panama 2
SR - Suriname 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
GN - Guinea 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
Totale 17.913
Città #
Singapore 1.103
Fairfield 1.070
Ashburn 1.048
Woodbridge 983
Houston 607
San Jose 537
Chandler 460
Jacksonville 436
Seattle 429
Ann Arbor 420
Santa Clara 392
Beijing 371
Hong Kong 354
Wilmington 347
Cambridge 332
Izmir 184
Munich 181
Ho Chi Minh City 166
Los Angeles 162
Warsaw 148
Dallas 127
Nanjing 126
New York 119
Ferrara 116
Hanoi 113
Princeton 100
Helsinki 95
Tokyo 91
San Diego 89
Lauterbourg 78
Boardman 74
São Paulo 65
Milan 61
Shanghai 57
Jakarta 55
Orem 51
Mexico City 48
London 47
Turku 46
Nanchang 42
Bremen 41
Chicago 41
Falls Church 41
Council Bluffs 39
Dearborn 34
Montreal 34
Tianjin 32
Atlanta 29
Brooklyn 29
Buffalo 28
Hebei 28
Shenyang 27
Toronto 27
Brussels 26
The Dalles 26
Changsha 25
Frankfurt am Main 25
Johannesburg 25
Denver 24
Haiphong 24
Hefei 23
Jiaxing 23
Addison 21
Amsterdam 21
Da Nang 20
Poplar 20
Stockholm 20
Ankara 19
Boston 19
Jinan 19
Phoenix 19
Falkenstein 18
Manchester 18
Mountain View 18
Nuremberg 18
Rio de Janeiro 18
Chennai 17
Hangzhou 17
Timisoara 17
Vienna 17
Baghdad 16
San Francisco 16
Moscow 15
Guangzhou 14
Norwalk 14
Tashkent 14
Bologna 13
Columbus 13
Dong Ket 13
Kunming 13
Hải Dương 12
Washington 12
Belo Horizonte 11
Curitiba 11
Mumbai 11
Ningbo 11
Philadelphia 11
Querétaro 11
Rome 11
Zhengzhou 11
Totale 12.570
Nome #
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 369
Absolute quantification of cell-free microRNAs in cancer patients 328
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 317
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 305
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 298
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 283
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 280
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 258
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 257
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 247
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 242
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 236
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 233
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 233
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 231
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 230
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 229
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 227
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines 222
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 217
A microRNA signature of hypoxia 214
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 212
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 209
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 208
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 204
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 200
Espressione dei MicroRNA nei carcinomi mammari 197
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 191
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 190
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 190
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 190
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice 188
Tumor suppressor functions of ARLTS1 in lung cancers 185
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 185
Extensive modulation of a set of microRNAs in primary glioblastoma 183
Mutated beta-catenin evades a microRNA-dependent regulatory loop 183
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 180
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 179
MicroRNA deregulation in human thyroid papillary carcinomas 176
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 175
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 174
The Role of Micro-RNAs in Rheumatic Diseases: An Update 170
MicroRNAs in cancer (an overview) 170
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 169
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 168
Oncogenic role of miR-483-3p at the IGF2/483 locus 168
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 168
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 168
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 168
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 166
Modulation of mismatch repair and genomic stability by miR-155 165
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 162
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 159
Regulation of microRNA expression: the hypoxic component 158
Micro-RNA profiling in kidney and bladder cancers 157
A microRNA expression signature of human solid tumors defines cancer gene targets 157
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 157
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome 155
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 152
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 151
Principles of MicroRNA involvement in breast cancer 150
Hemostasis gene expression of the internal jugular and saphenous veins 150
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 146
MicroRNAs and Their Role in Cancer 143
Micro-markers: microRNAs in cancer diagnosis and prognosis 141
OncomiR detection in circulating body fluids: A PDMS microdevice perspective 139
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. 139
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells 138
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts 138
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma 134
First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) 133
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 133
MicroRNAs as biomarker of Parkinson disease? Small but mighty. 132
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells 132
miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy 130
MicroRNAs: toward the clinic for breast cancer patients 125
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 124
MiR-15a and miR-16-1 cluster functions in human leukemia 121
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 118
MicroRNA coinvolti nello sviluppo del carcinoma epatocellulare. Identificazione delle proteine bersaglio. 117
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 113
MicroRNA gene expression deregulation in human breast cancer 112
null 111
Karyotype-specific microRNA signature in chronic lymphocytic leukemia 109
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas 107
Familial cancer associated with a polymorphism in ARLTS1 104
null 101
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review 101
Involvement of the Inconstant Bursa of the Fifth Metatarsophalangeal Joint in Psoriatic Arthritis: A Clinical and Ultrasonographic Study 98
null 96
Progetto triennale AIRC (MFAG 2011). Titolo: Circulating microRNAs as cancer-specific biomarkers 96
The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile 95
null 94
null 94
null 93
null 91
null 89
null 89
null 89
Totale 17.114
Categoria #
all - tutte 74.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.343
Totale 77.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021491 0 0 0 0 0 0 0 0 0 171 203 117
2021/20221.191 54 107 107 31 56 74 78 57 39 84 113 391
2022/20231.051 114 77 35 156 161 166 40 76 121 12 47 46
2023/2024561 70 63 23 8 43 111 27 35 10 22 9 140
2024/20252.571 43 46 181 121 316 251 118 143 482 238 362 270
2025/20266.089 673 211 522 842 887 417 869 413 680 575 0 0
Totale 18.104